About This Book
Why did COVID-19 disproportionately claim the lives of older adults? *Elderly Risks* investigates the increased vulnerability of seniors to infectious diseases, particularly focusing on the factors that contributed to the higher COVID-19 mortality rates in this demographic and how vaccines played a crucial role in mitigating these risks. This book delves into the complex interplay of age-related physiological changes, pre-existing conditions, and immunological responses that rendered older individuals more susceptible to severe outcomes from COVID-19. We examine the key factors that elevate the risk for older adults, including immunosenescence—the gradual decline of the immune system with age—and inflammaging—a chronic, low-grade inflammation state that can impair immune function. The book also explores the prevalence of comorbidities such as cardiovascular disease, diabetes, and respiratory illnesses, which often exacerbate the severity of viral infections in seniors. Understanding these underlying mechanisms is critical for developing targeted interventions and public health strategies to protect this vulnerable population. *Elderly Risks* builds upon a foundation of scientific literature, epidemiological data, and clinical studies. We analyze data from global health organizations, government agencies, and peer-reviewed research to provide a comprehensive understanding of the pandemic's impact on older adults. The influence of social determinants of health, such as access to healthcare, socioeconomic status, and living arrangements, are also considered to offer a holistic view of the challenges faced by seniors during the pandemic. Our central argument is that the heightened vulnerability of older adults to COVID-19 underscores the urgent need for age-focused public health policies, improved geriatric care, and continued research into age-related immune dysfunction. The book advocates for proactive strategies to enhance the resilience of older populations against future infectious disease threats. The book is structured into three parts. Part One introduces the concept of aging as a risk factor for infectious diseases, detailing the biological and immunological changes that occur with age. Part Two analyzes the specific challenges posed by COVID-19 to older adults, examining the clinical manifestations, complications, and mortality rates in this population. Part Three focuses on the role of vaccines in preventing severe outcomes, assessing vaccine efficacy and safety, and addressing vaccine hesitancy among seniors. It also considers the implications of long-term care facilities as epicenters of infection and explores strategies for mitigating the spread of disease within these settings. The culmination of our analysis leads to practical recommendations for improving geriatric care, enhancing pandemic preparedness, and promoting healthy aging. The evidence presented throughout the book relies on a synthesis of epidemiological studies, immunological assays, and clinical trial data. We draw upon unique data sources, including longitudinal studies of aging and real-world evidence from vaccine surveillance programs, to provide robust support for our arguments. *Elderly Risks* connects to several interdisciplinary fields, including gerontology, immunology, public health, and health policy. By integrating perspectives from these disciplines, the book provides a more comprehensive understanding of the complex factors that influence the health and well-being of older adults. Our approach emphasizes actionable insights for healthcare professionals, policymakers, and caregivers. While acknowledging the breadth of research on aging and infectious diseases, the scope is intentionally focused on COVID-19 as a case study to highlight broader principles of geriatric vulnerability. The insights offered can be applied practically by healthcare providers to improve the diagnosis and management of COVID-19 in older adults. Public health officials can use the information to develop targeted vaccination campaigns and implement infection control measures in long-term care facilities. Family members and caregivers can gain a deeper understanding of the risks faced by their loved ones and make informed decisions about their care. The book appeals to a broad audience, including healthcare professionals, researchers, policymakers, and anyone interested in understanding the impact of infectious diseases on older adults. It offers valuable insights for those seeking to improve the health and well-being of seniors in the face of ongoing and future public health challenges. As a work of non-fiction in the infectious disease and public health genres, *Elderly Risks* aims to provide objective, evidence-based information to inform decision-making and promote informed discussions.
Why did COVID-19 disproportionately claim the lives of older adults? *Elderly Risks* investigates the increased vulnerability of seniors to infectious diseases, particularly focusing on the factors that contributed to the higher COVID-19 mortality rates in this demographic and how vaccines played a crucial role in mitigating these risks. This book delves into the complex interplay of age-related physiological changes, pre-existing conditions, and immunological responses that rendered older individuals more susceptible to severe outcomes from COVID-19. We examine the key factors that elevate the risk for older adults, including immunosenescence—the gradual decline of the immune system with age—and inflammaging—a chronic, low-grade inflammation state that can impair immune function. The book also explores the prevalence of comorbidities such as cardiovascular disease, diabetes, and respiratory illnesses, which often exacerbate the severity of viral infections in seniors. Understanding these underlying mechanisms is critical for developing targeted interventions and public health strategies to protect this vulnerable population. *Elderly Risks* builds upon a foundation of scientific literature, epidemiological data, and clinical studies. We analyze data from global health organizations, government agencies, and peer-reviewed research to provide a comprehensive understanding of the pandemic's impact on older adults. The influence of social determinants of health, such as access to healthcare, socioeconomic status, and living arrangements, are also considered to offer a holistic view of the challenges faced by seniors during the pandemic. Our central argument is that the heightened vulnerability of older adults to COVID-19 underscores the urgent need for age-focused public health policies, improved geriatric care, and continued research into age-related immune dysfunction. The book advocates for proactive strategies to enhance the resilience of older populations against future infectious disease threats. The book is structured into three parts. Part One introduces the concept of aging as a risk factor for infectious diseases, detailing the biological and immunological changes that occur with age. Part Two analyzes the specific challenges posed by COVID-19 to older adults, examining the clinical manifestations, complications, and mortality rates in this population. Part Three focuses on the role of vaccines in preventing severe outcomes, assessing vaccine efficacy and safety, and addressing vaccine hesitancy among seniors. It also considers the implications of long-term care facilities as epicenters of infection and explores strategies for mitigating the spread of disease within these settings. The culmination of our analysis leads to practical recommendations for improving geriatric care, enhancing pandemic preparedness, and promoting healthy aging. The evidence presented throughout the book relies on a synthesis of epidemiological studies, immunological assays, and clinical trial data. We draw upon unique data sources, including longitudinal studies of aging and real-world evidence from vaccine surveillance programs, to provide robust support for our arguments. *Elderly Risks* connects to several interdisciplinary fields, including gerontology, immunology, public health, and health policy. By integrating perspectives from these disciplines, the book provides a more comprehensive understanding of the complex factors that influence the health and well-being of older adults. Our approach emphasizes actionable insights for healthcare professionals, policymakers, and caregivers. While acknowledging the breadth of research on aging and infectious diseases, the scope is intentionally focused on COVID-19 as a case study to highlight broader principles of geriatric vulnerability. The insights offered can be applied practically by healthcare providers to improve the diagnosis and management of COVID-19 in older adults. Public health officials can use the information to develop targeted vaccination campaigns and implement infection control measures in long-term care facilities. Family members and caregivers can gain a deeper understanding of the risks faced by their loved ones and make informed decisions about their care. The book appeals to a broad audience, including healthcare professionals, researchers, policymakers, and anyone interested in understanding the impact of infectious diseases on older adults. It offers valuable insights for those seeking to improve the health and well-being of seniors in the face of ongoing and future public health challenges. As a work of non-fiction in the infectious disease and public health genres, *Elderly Risks* aims to provide objective, evidence-based information to inform decision-making and promote informed discussions.
*Elderly Risks* explores why older adults faced disproportionately high mortality rates during the COVID-19 pandemic. It examines how age-related immune decline, known as immunosenescence, and chronic inflammation, referred to as inflammaging, increased seniors' susceptibility to severe outcomes. The book highlights the significance of comorbidities, such as cardiovascular disease and diabetes, in exacerbating the effects of viral infections in this vulnerable population. Public health strategies and geriatric care improvements are emphasized as crucial for protecting older adults. Investigating the pandemic's impact, the book analyzes global health data and clinical studies. It considers how social determinants like healthcare access and socioeconomic status influenced the challenges faced by seniors. Vaccines played a pivotal role in mitigating risks, making vaccine efficacy and safety key topics. The book progresses through three parts, first introducing aging as a risk factor, then analyzing COVID-19's specific challenges for older adults, and finally focusing on the role of vaccines. Ultimately, *Elderly Risks* advocates for age-focused public health policies and proactive measures to enhance the resilience of older populations against future infectious disease threats. Its comprehensive approach integrates perspectives from gerontology, immunology, public health, and health policy, offering actionable insights for healthcare professionals, policymakers, and caregivers alike.
Book Details
ISBN
9788235273321
Publisher
Publifye AS
Your Licenses
You don't own any licenses for this book
Purchase a license below to unlock this book and download the EPUB.
Purchase License
Select a tier to unlock this book
Need bulk licensing?
Contact us for enterprise agreements.